Dolly Vance | Executive Vice President-Corporate Affairs and General Counsel |
Raul Rodriguez | President and Chief Executive Officer |
Dave Santos | Chief Commercial Officer |
Wolfgang Dummer | Executive Vice President and Chief Medical Officer |
Dean Schorno | Executive Vice President and Chief Financial Officer |
Yigal Nochomovitz | Citigroup |
Eun Yang | Jefferies |
Do Kim | BMO Capital Markets |
Chris Raymond | Piper Sandler |
Joseph Pantginis | H.C. Wainwright |
Kristen Kluska | Cantor Fitzgerald |
Greetings, and welcome to the Rigel Pharmaceuticals’ Financial Conference Call for the First Quarter of 2021. At this time, all participants are in a listen-only mode. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce our first speaker, Dolly Vance, who is Rigel’s Executive Vice President, Corporate Affairs and General Counsel. Thank you, Ms.